Gujarat Themis Biosyn Issues Clarifications on Preferential Issue
Gujarat Themis Biosyn Ltd · Others (Uncategorized) · 04 Nov 2026, 11:13 pm
Gujarat Themis Biosyn Issues Clarifications on Preferential Issue Gujarat Themis Biosyn released additional disclosures regarding its proposed preferential issue of up to 82,10,786 equity shares (face value ₹1 each) at ₹408 per share to secure in-principle stock exchange approval. The company clarified that the 12-month timeline for utilizing issue proceeds starts from the share allotment date. It also identified ultimate beneficial owners for proposed allottees: Special Situation India Fund (Srinath Narasimhan, Pankaj Kalra, Jigar Karania) and India Special Assets Fund III alongside ISAF III Onshore Fund (Amit Agarwal, Navin Sambtani, Kriti Ghosh).
Original exchange filing (PDF)
More announcements from Gujarat Themis Biosyn Ltd
- Recording of Analysts Meet held on 16.11.2026 · 17 Nov 2026
- Please refer to the attached Analysts Presentation · 16 Nov 2026
- Please refer to the attachment · 16 Nov 2026
- Please refer to the intimation of resignation of Company Secretary & Compliance Officer. · 15 Nov 2026
- Please refer to the attachment · 14 Nov 2026
- Kindly refer to the Un-audited Standalone & Consolidated Financial Results for the quarter and half year ended 30.09.2026 · 14 Nov 2026
- Gujarat Themis Biosyn Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Outcome of the Board Meeting held on 14.11.2026 · 14 Nov 2026
